tradingkey.logo
tradingkey.logo
Suchen

Co-Diagnostics Inc

CODX
Zur Watchlist hinzufügen
2.990USD
-0.090-2.92%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
10.77MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Co-Diagnostics Inc Unternehmen

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc Informationen

BörsenkürzelCODX
Name des UnternehmensCo-Diagnostics Inc
IPO-datumJul 12, 2017
CEOEgan (Dwight H)
Anzahl der mitarbeiter132
WertpapierartOrdinary Share
GeschäftsjahresendeJul 12
Addresse2401 S. Foothill Dr. Suite D
StadtSALT LAKE CITY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl84109
Telefon18014381036
Websitehttps://codiagnostics.com/
BörsenkürzelCODX
IPO-datumJul 12, 2017
CEOEgan (Dwight H)

Führungskräfte von Co-Diagnostics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Co-Diagnostics Inc?

Die fünf größten Anteilseigner von Co-Diagnostics Inc sind: Mr. Richard S. Serbin

Wie viele Institutionen halten Anteile an Co-Diagnostics Inc (CODX)?

Mit Stand vom 2026Q1 halten 75 Institutionen Anteile an Co-Diagnostics Inc, mit einem Gesamtmarktwert von etwa 248.15K, was 6.89% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -158736.00 gestiegen.